First death from H5N5 bird flu recorded in America. Learn how the virus spreads, what the symptoms are, and essential measures to keep your family safe.

Tia here with news that a trial of the pill form of the GLP-1 drug semaglutide has failed to delay Alzheimer's progression in a big, phase III trial, drugmaker Novo Nordisk reported today (Nov. 24). As a result, the Nordic drug giant is now cutting the cord on another big trial testing the injectable form of semaglutide for Alzheimer's.

A Washington state resident died from the H5N5 avian flu, marking a first-known human case, with health officials maintaining a low risk to the public.

The man was taken to hospital with a high fever, confusion and respiratory distress earlier this month and was later confirmed to have H5N5